Refine by
Insulin Pump Articles & Analysis: Older
17 news found
(the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced an update on the development of its initial insulin pump product. ...
(the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, will be participating in the following investor conferences: Piper ...
An estimated 415 million people are living with diabetes in the world. Diabetes is a chronic disease, that causes blood sugar levels in your body to become too high, either due to your body not being able to respond properly to insulin or due to your body not being unable to produce any at all. If left untreated, this can lead to serious complications such as heart attack, stroke, obesity, eye ...
All patient respondents were checking their blood glucose at least weekly using a blood glucose meter, and either taking at least one oral medication, or administering non-insulin or insulin injections, or using an insulin ...
ByLifeScan
(the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today provided an update on its insulin pump product. ...
Kevin will have a very significant role in Modular Medical's strategic direction and growth," said Paul DiPerna, Modular Medical's President and Chief Technology Officer. "I believe Modular Medical's insulin delivery platform represents a tremendous opportunity to bring an easy-to-use, cost-effective insulin delivery system to millions of people managing ...
Senstech sensors can be found in a variety of applications in the medical field, such as infusion or insulin pumps, in cardiotocography or in devices for eye surgery. Other important areas of application are textile machinery, mechanical engineering, the watch industry, industrial pressure measurement technology, and applications for cars. ...
In less than three months, more than 85 patients participated in the research study, providing qualitative and quantitative data on the quality of life for Type 1 diabetics using insulin pumps compared to daily insulin injections. The study sponsors used participant data to evaluate the efficiency of local reimbursement policies for ...
(the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, is scheduled to present at the LD Micro Invitational XII Investor ...
The abstract posted today, describing an online survey of 2,044 adults with T1D in the T1D Exchange registry and online communities, shows that in patients with high rates of diabetes technology adoption, such as continuous glucose monitoring, insulin pumps and hybrid closed loop systems, impaired awareness of hypoglycemia (IAH) and severe hypoglycemic events ...
“If we can bend the curve of health care by creating an industry to cure conditions as opposed to treat them, if you could eliminate the need for dialysis, eliminate the need for insulin pumps, eliminate the need to be on a waiting list for a cadaver organ to get you a kidney or a liver or an arm — if you can manufacture these things, the impact on ...
Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, announced today the pricing of its ...
(the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced the expansion of its Board of Directors with the ...
(the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced a "reverse split" of its shares of common stock at a ratio of ...
(OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced the expansion of its executive team with the appointment of Lynn O'Connor Vos as its ...
Hypoglycemia is a well-documented problem for people with diabetes taking insulin. Continuous glucose monitor (CGM) technologies are increasingly used by insulin users, and are believed to be of great support to patients in reacting to impending hypoglycemia by alerting the patient to falling glucose levels. ...
Founded in 1994, CCS Medical is a leading provider of medical supplies assisting patients that need diabetes test strips, insulin pumps, urological supplies, ostomy supplies, advanced wound care dressings and prescription drugs. ...